Key result
The ACE D/D genotype was present in 25.3% of VTE cases and 32.4% of controls, indicating a protective effect against idiopathic venous thromboembolism.
Why the study?
Is the ACE D/D genotype independently associated with the occurrence of idiopathic venous thromboembolic disease?
Case-Control (n=600)
Is the ACE D/D genotype independently associated with the occurrence of idiopathic venous thromboembolic disease?
The ACE D/D genotype is associated with a reduced risk of idiopathic venous thromboembolism, suggesting a protective effect.
Answers are grounded in this paper and cite their sources.
ACE D/D genotype was associated with lower idiopathic VTE risk; leaves open any role in risk stratification pending prospective validation.
The deletion/deletion (D/D) genotype of the angiotensin converting enzyme (ACE) has been purported to be a risk for post-operative thrombosis.This D/D genotype has not been evaluated as a risk factor for idiopathic venous thromboembolism (VTE). The primary objective of the present study was to determine whether the D/D genotype of ACE is independently associated with the occurrence of idiopathic venous thromboembolic disease. We prospectively enrolled consecutive patients with at least one objectively confirmed idiopathic VTE. Friends of cases were recruited as controls and matched to cases by sex, ethnicity, and age. Patients were tested for the ACE I/D polymorphism in addition to factor V Leiden, prothrombin G20210A, and factor VIII levels. Three hundred cases and 300 controls were enrolled; 97% were Caucasian. There were 148 females and 152 males in each group with a mean age of 56.21 years (SD = 15.33). The ACE D/D genotype was present in 25.3% of cases and 32.4% of controls for an adjusted odds ratio of 0.66 (95% CI = 0.433 to 0.997). We can conclude that the ACE D/D genotype is protective against idiopathic venous thromboembolism.
No takes yet. Share an insight, caveat, or question.
Rodger et al. (2003) conducted a case-control in Idiopathic venous thromboembolism (VTE) (n=600). ACE D/D genotype vs. Controls without VTE was evaluated on Idiopathic venous thromboembolic disease (adjusted OR 0.66, 95% CI 0.433 to 0.997). The ACE D/D genotype was present in 25.3% of VTE cases and 32.4% of controls, indicating a protective effect against idiopathic venous thromboembolism.
Synapse has enriched 10 related papers. Consider them for comparative context: